<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10221884</article-id><article-id pub-id-type="pmc">2640692</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jackson</surname><given-names>L. A.</given-names></name><email>lajack@u.washington.edu</email></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>N. L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heckbert</surname><given-names>S. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grayston</surname><given-names>J. T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Siscovick</surname><given-names>D. S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Psaty</surname><given-names>B. M.</given-names></name></contrib></contrib-group><aff>University of Washington, Seattle, USA.</aff><pub-date pub-type="ppub"><season>Mar-Apr</season><year>1999</year></pub-date><volume>5</volume><issue>2</issue><fpage>281</fpage><lpage>284</lpage><abstract><p>To evaluate the association of prior treatment with antibiotics active against Chlamydia pneumoniae with the risk for incident myocardial infarction, we conducted a population-based case-control study. We found that use of erythromycin, tetracycline, or doxycycline during the previous 5 years was not associated with risk for first myocardial infarction. These results suggest little or no association between the use of these antibiotics and the risk for first myocardial infarction in the primary prevention setting.</p></abstract></article-meta></front></article>